NEW YORK, June 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GERN, VXRT, ORPH, ATHA, and TAL.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • GERN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=GERN&prnumber=061820211
  • VXRT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=VXRT&prnumber=061820211
  • ORPH: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ORPH&prnumber=061820211
  • ATHA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATHA&prnumber=061820211
  • TAL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TAL&prnumber=061820211

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-geron-corp-vaxart-orphazyme-athira-pharma-or-tal-education-301315423.html

SOURCE InvestorsObserver